垂体促甲状腺素腺瘤的研究进展(1)
[摘要] 垂體促甲状腺素腺瘤(thyrotropinomas,TSH瘤)是来源于垂体促甲状腺细胞的肿瘤。此种垂体瘤发病率较低,自首例TSH瘤报道至今全球报道的病例数约450多例。TSH瘤的临床表现为甲状腺功能亢进症。实验室检查可见甲状腺激素水平增高,促甲状腺激素水平不被抑制。垂体核磁(Magnetic resonance imaging,MRI)提示鞍区占位。目前首选治疗方法为经碟手术切除肿瘤,此外还有放射治疗、药物治疗。但TSH瘤多为侵袭性肿瘤,单一手术难以彻底治愈,所以多采用手术结合药物进行治疗,与单一药物治疗TSH瘤的方法被国内外医生广泛重视。目前国内外有关于手术结合药物治疗的报道不占少数,但关于单一运用药物治疗TSH瘤的报道甚少。
[关键词] 垂体促甲状腺素腺瘤;弥漫性毒性甲状腺肿;甲状腺激素抵抗
[中图分类号] R736 [文献标识码] A [文章编号] 1673-9701(2016)33-0165-04
[Abstract] Pituitary thyrotropinoma(TSH) adenoma is a tumor derived from pituitary thyrotropin-secreting cells. The incidence of this pituitary tumor is low ......
您现在查看是摘要页,全文长 3932 字符。
[关键词] 垂体促甲状腺素腺瘤;弥漫性毒性甲状腺肿;甲状腺激素抵抗
[中图分类号] R736 [文献标识码] A [文章编号] 1673-9701(2016)33-0165-04
[Abstract] Pituitary thyrotropinoma(TSH) adenoma is a tumor derived from pituitary thyrotropin-secreting cells. The incidence of this pituitary tumor is low ......
您现在查看是摘要页,全文长 3932 字符。